RECRUITING Not applicable ClinicalTrials.gov

Short Term Effects of a Multimodal Intervention With RGM on Cognition in People With Parkinson's Disease.

Sponsor: University Ghent • ClinicalTrials.gov ID: NCT07863219

Registry updated: 2026-10-07

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

The goal of this clinical trial is to learn if the Ronnie Gardiner Method (RGM) works to improve cognitive functions in adults with Parkinson's disease (early to mid-stage). It will also learn about the secondary effects on speech, mobility, balance, and mood. The main questions it aims to answer are: * Does a 10-week RGM intervention improve cognitive aspects, speech (indirectly through improved breathing), mobility, and balance in participants with Parkinson's disease? * How do participants experience the intensity, difficulty, and emotional impact of the RGM sessions?

Interventions

Ronnie Gardiner Method (Other)
1. Warm-up (10 min): light rhythmic movements to music; activation of coordination and attention. 2. RGM Block 1 (30 min): cognitive-motor exercises incorporating color, sound, and movement elements (bilateral). 3. Strength or interval segment (10 min): short strength/conditioning exercises (Tabata style) alternating between 20 seconds of activity and 20 seconds of rest. The exercises focus on strengthening postural muscles, improving rotation, encouraging weight shifting, and initiating movement quickly (the 4 principles of the PWR! concept). 4. 10-minute break 5. RGM Block 2 (30 min): cognitive-motor exercises incorporating color, sound, and movement elements (bilateral). 6. Cool-down (10 min): relaxation, breathing, evaluation. Cognitive component During the sessions, executive functions, attention, and processing speed are challenged and practiced through dual-task situations, pattern recognition, and auditory response tasks. Home exercises After each session, participants are gi

Eligibility criteria

Inclusion Criteria: * diagnosis of idiopathic Parkinson's disease * safe, independent mobility and participation (Hoehn and Yahr stages 1-3) * a stable dopaminergic medication regimen for at least 4 weeks prior to study participation * willingness and ability to participate in a 10-week intervention program * willingness to participate in the study (signing of informed consent) Exclusion Criteria: * Presence of other neurological or severe psychiatric conditions that could interfere with participation or the interpretation of results (e.g., substance use disorder, severe depression, psychosis) * Severe visual or hearing impairments that limit the ability to follow group instructions as determined by a physician. * Physical limitations that inhibit safe participation in moderate-to-vigorous exercise or group rehabilitation.

Conditions

Parkinson Disease (PD) Cognition Quality of Life Functional Mobility

Locations

University Hospital Ghent — Ghent, Oost-Vlaanderen, Belgium

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment